Zepp Health Corporation
FRC CoverageZepp Health Corporation
FRC CoverageYour view on ZEPP
Overview
What the company does, where it operates, and who runs it.
*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.
About Zepp Health Corporation
- Industry
- Consumer Electronics
- Sector
- Technology
- CEO
- Wang Huang
- Headquarters
- Edisonweg 44 – B08 | Gorinchem, Zuid-Holland, Gorinchem, Zuid-Holland, NL
- Industry
- Consumer Electronics
- Sector
- Technology
- CEO
- Wang Huang
- Headquarters
- Edisonweg 44 – B08 | Gorinchem, Zuid-Holland, Gorinchem, Zuid-Holland, NL
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.
The company offers smart bands, watches, scales, and rings; and associated accessories, smart hearable products, sportswear, home appliances, and smart watch accessories.
It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps.
It offers its products under the Amazfit and Zepp brand names in approximately 90 countries.
Sign in to view
Sign in to view
Research Reports
FRC analyst coverage and recommendations.
Research Reports
10 reports*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.
Premiumization Gains Traction as Global Smartwatch Shipments Contract
We reiterate our BUY rating, and lower our fair value estimate from $53.01 to $43.86/share.

Outgrowing the Market, Trading Below Liquid Assets
Zepp Health Corporation reported flat EPS of ($0.08) and lowered its FY2026 revenue growth forecast to 21% after Q2 guidance came in below expectations.

Strong Execution, Deep Discount: Market Missing the Turnaround
Zepp Health Corporation expects Q1-2026 revenue of $50–55M, driven by new product launches and a positive EPS outlook for 2026.

Past Reports
Historical coverage archive.
A Leading Smartwatch Maker Trading Below Liquid Assets - Initiating Coverage
Analyst Notes
Ongoing commentary and updates from FRC analysts.
*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.
Company announcement
Launches Amazfit Cheetah 2 Pro (All figures in US$)
Amazfit’s Cheetah 2 Pro is a marathon-focused smartwatch competing with mid-to-premium running watches from Apple, Garmin, and others. It offers coaching plans, tracks key fitness data like heart rate and stamina, provides accurate GPS tracking, and has a lightweight but durable build, with about 29 hours of GPS battery life. It also supports major fitness apps. Early reviews suggests it delivers strong value at around $449 with many high-end features, but it is still less refined than Garmin’s ecosystem. Overall, we believe it looks like a solid, affordable option for serious runners, and a competitive addition to Zepp’s portfolio, though it still needs time to prove itself against established leaders.
We are anticipating Q1 results next month. In 2025, revenue rose 41% YoY to $259M, and EPS improved from ($0.29) to ($0.16). With recent product launches, we expect EPS to turn positive this year, potentially ending a five-year streak of losses. ZEPP trades at 0.45x forward revenue vs the sector average of 3.27x, an 86% discount.
Company announcement
Partners with Olympic Medalist Josh Kerr
Zepp has partnered with Scottish middle-distance runner Josh Kerr, a gold medalist at the 2023 World Championships, silver medalist at the 2024 Olympics, and bronze medalist at the 2020 Olympics. Kerr joins an extensive roster of athletes promoting Zepp’s products, providing a strong testimonial and real-world validation of its wearables. Q3-2025 revenue was up 78% YoY, and management expects Q4 revenue to grow 40% YoY, with results due in the coming weeks. Notably, we anticipate EBITDA turning positive, representing a key milestone for the company.
Company announcement
New products/concepts
Last week, Zepp Health attended CES 2026 in Las Vegas, one of the world’s largest tech shows, where it unveiled new products and upcoming concepts. As we noted last week, Zepp’s latest launch includes the Amazfit Active Max, a mid-tier, fitness-focused smartwatch that competes with budget- to mid-range offerings from Fitbit (NASDAQ: GOOGL), Garmin (NYSE: GRMN), and Samsung (KOSE: 005930). Zepp also showcased new concepts, including a food camera that tracks meals and links them to training and recovery, and smart glasses that display pace, heart rate, and navigation in a runner’s view for safer, hands-free workouts. While no other major wearables company currently offers these products, we note that they may be developing similar features. The key takeaway is that Zepp is actively innovating to stay ahead.
Media
Infographics, videos, and posts covering the company.
X (Twitter)
2 postsStock Data
Price chart, volume, and trading data.
FRC Analyst Fair Value
FRC's analysts' fair value estimate and rating, from their research on the company.
About this section
FRC's fair value estimate for Zepp Health Corporation, and the rating behind it. ZEPP last traded at $2.54; the estimate is read against that market price. Set by FRC's analysts in their research on the company: the current estimate, the rating, and when it was last revised. Included with a free account.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Zepp Health Corporation. Starting points for Zepp Health Corporation: EPS -$304.63, beta 1.93 — an Consumer Electronics name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Zepp Health Corporation. Zepp Health Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Zepp Health Corporation. Trailing twelve-month EPS for Zepp Health Corporation stands at -$304.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$12.00
average of analysts' targets
Earnings Estimate
| EPS | Current QtrDec 2021 | Next QtrMar 2022 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | CNY 9.43 | CNY 1.58 | -CNY 0.70 | -CNY 0.28 |
| Low estimate | CNY 9.43 | CNY 1.58 | -CNY 0.70 | -CNY 0.28 |
| High estimate | CNY 9.43 | CNY 1.58 | -CNY 0.70 | -CNY 0.28 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | — | — | -CNY 283.041 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2021 | Next QtrMar 2022 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | CNY 1.86B | CNY 961.18M | CNY 2.13B | CNY 2.27B |
| Low estimate | CNY 1.86B | CNY 961.18M | CNY 2.13B | CNY 2.27B |
| High estimate | CNY 1.86B | CNY 961.18M | CNY 2.13B | CNY 2.27B |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | — | — | CNY 1.82B | — |
| Growth | — | — | +17.2% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Zepp Health Corporation. Zepp Health Corporation has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ARAIArrive AI Inc.Software - Application$3M
- BWBabcock & Wilcox Enterprises, Inc.Industrial - Machinery$630M
- EXFYExpensify, Inc.Software - Application$165M
- KULRKULR Technology Group, Inc.Industrial - Machinery$74M
- STEMStem, Inc.Renewable Utilities$19M
- SVCOSilvaco Group, Inc. Common StockSoftware - Application$237M
- TROOTROOPS, Inc.Financial - Credit Services$160M
- TTECTTEC Holdings, Inc.Information Technology Services$152M
More Consumer Electronics companies
- SONYSony Group CorporationNYSE$161.1B
- SSNLFSamsung Electronics Co., Ltd.OTC$383.2B
- SWDHFSkyworth Group LimitedOTC$984M
- SWDHYSkyworth Group LimitedOTC$780M
- TBCHTurtle Beach CorporationNASDAQ$286M
- TCLHFTCL Electronics Holdings LimitedOTC$4.1B
- UEICUniversal Electronics Inc.NASDAQ$78M
- VTEPFVidendum PlcOTC$19M
- VUZIVuzix CorporationNASDAQ$102M
- WLDSWearable Devices Ltd.NASDAQ$3M
- WLDSWWearable Devices Ltd.NASDAQ$9M
- XIACFXiaomi CorporationOTC$118.3B
ETFs holding Zepp Health Corporation
% of the fund
- SNSRGlobal X - Internet of Things ETF$193M in assets0.04%
Largest holders first, then the funds most concentrated in ZEPP.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Zepp Health Corporation, and how their positions are changing. At a $36.4M market value, institutional positions materially move Zepp Health Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Zepp Health Corporation executives and directors. Shares of Zepp Health Corporation have traded between $2.13 and $61.85 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Zepp Health Corporation. Coverage tracks Zepp Health Corporation within Consumer Electronics (Technology). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Zepp Health Corporation.